265 related articles for article (PubMed ID: 19008348)
1. Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice.
Rountree CB; Ding W; He L; Stiles B
Stem Cells; 2009 Feb; 27(2):290-9. PubMed ID: 19008348
[TBL] [Abstract][Full Text] [Related]
2. CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis.
Ding W; Mouzaki M; You H; Laird JC; Mato J; Lu SC; Rountree CB
Hepatology; 2009 Apr; 49(4):1277-86. PubMed ID: 19115422
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion.
Ding W; You H; Dang H; LeBlanc F; Galicia V; Lu SC; Stiles B; Rountree CB
Hepatology; 2010 Sep; 52(3):945-53. PubMed ID: 20564331
[TBL] [Abstract][Full Text] [Related]
4. Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice.
Rountree CB; Senadheera S; Mato JM; Crooks GM; Lu SC
Hepatology; 2008 Apr; 47(4):1288-97. PubMed ID: 18167064
[TBL] [Abstract][Full Text] [Related]
5. A CD133-expressing murine liver oval cell population with bilineage potential.
Rountree CB; Barsky L; Ge S; Zhu J; Senadheera S; Crooks GM
Stem Cells; 2007 Oct; 25(10):2419-29. PubMed ID: 17585168
[TBL] [Abstract][Full Text] [Related]
6. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
7. Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.
Yang Z; Zhang L; Ma A; Liu L; Li J; Gu J; Liu Y
PLoS One; 2011; 6(12):e28405. PubMed ID: 22145042
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.
Zhang L; Li H; Ge C; Li M; Zhao FY; Hou HL; Zhu MX; Tian H; Zhang LX; Chen TY; Jiang GP; Xie HY; Cui Y; Yao M; Li JJ
Oncotarget; 2014 Nov; 5(21):10621-35. PubMed ID: 25301737
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver.
Suzuki A; Sekiya S; Onishi M; Oshima N; Kiyonari H; Nakauchi H; Taniguchi H
Hepatology; 2008 Dec; 48(6):1964-78. PubMed ID: 18837044
[TBL] [Abstract][Full Text] [Related]
10. PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.
Cheng RB; Ma RJ; Wang ZK; Yang SJ; Lin XZ; Rong H; Ma Y
Mol Cell Biochem; 2011 Mar; 349(1-2):149-57. PubMed ID: 21110069
[TBL] [Abstract][Full Text] [Related]
11. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
[TBL] [Abstract][Full Text] [Related]
12. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY
Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
[TBL] [Abstract][Full Text] [Related]
13. Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.
Chen WC; Chang YS; Hsu HP; Yen MC; Huang HL; Cho CY; Wang CY; Weng TY; Lai PT; Chen CS; Lin YJ; Lai MD
Oncotarget; 2015 Dec; 6(40):42923-37. PubMed ID: 26556861
[TBL] [Abstract][Full Text] [Related]
14. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
15. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
[TBL] [Abstract][Full Text] [Related]
16. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W
Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217
[TBL] [Abstract][Full Text] [Related]
17. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
[TBL] [Abstract][Full Text] [Related]
18. CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.
Zhang SS; Han ZP; Jing YY; Tao SF; Li TJ; Wang H; Wang Y; Li R; Yang Y; Zhao X; Xu XD; Yu ED; Rui YC; Liu HJ; Zhang L; Wei LX
BMC Med; 2012 Aug; 10():85. PubMed ID: 22871210
[TBL] [Abstract][Full Text] [Related]
19. Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122.
Song K; Kwon H; Han C; Zhang J; Dash S; Lim K; Wu T
Oncotarget; 2015 Dec; 6(38):40822-35. PubMed ID: 26506419
[TBL] [Abstract][Full Text] [Related]
20. Podoplanin discriminates distinct stromal cell populations and a novel progenitor subset in the liver.
Eckert C; Kim YO; Julich H; Heier EC; Klein N; Krause E; Tschernig T; Kornek M; Lammert F; Schuppan D; Lukacs-Kornek V
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G1-12. PubMed ID: 26564718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
